Ownership history in UBS Group AG · 5 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in SUNSHINE BIOPHARMA INC (SBFM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 1,873 | +1,667 | +809.2% | 0.00% | $2K | $1.23 |
| 2025 Q3 | UNCHANGED | 206 | — | 0% | 0.00% | $307 | $1.49 |
| 2025 Q2 | REDUCED | 206 | -19,679 | -99.0% | 0.00% | $297 | $1.44 |
| 2025 Q1 | ADDED | 19,885 | +19,017 | +2190.9% | 0.00% | $38K | $1.91 |
As of 2025 Q4 — sorted by position size